Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin

A. H. Lashin,Y. A. Shaheen,Mohamed Metwally,H. M. El-Feky,M. F. Hegab,S. M. Abbas

Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin

2013

A. H. Lashin
Y. A. Shaheen
Mohamed Metwally
H. M. El-Feky
M. F. Hegab
S. M. Abbas

Aim The aim of this paper was to study the incidence and predictors of hematological abnormalities during treatment of chronic hepatitis C virus (HCV) patients with interferon and ribavirin.

Keywords:

Hepatitis C virus
Hepatitis C
Ribavirin
Interferon
Diabetes mellitus
Medicine
Virology
Pegylated interferon
Virus
Immunology
chronic hepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations